Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Oxidative Medicine and Cellular Longevity|June 20, 2019
Moringa oleifera Seeds Improve Aging-Related Endothelial Dysfunction in Wistar RatsJoseph Iharinjaka Randriamboavonjy, Sandrine Heurtebise, Pierre Pacaud, et al.Oxidative Medicine and Cellular Longevity|July 18, 2017
Moringa oleifera Seeds Attenuate Vascular Oxidative and Nitrosative Stresses in Spontaneously Hypertensive RatsJoseph Iharinjaka Randriamboavonjy, Marc Rio, Pierre Pacaud, et al.The Journal of Biological Chemistry|January 14, 2003
RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activationVincent Sauzeau, Malvyne Rolli-Derkinderen, Céline Marionneau, et al.Circulation Research|August 30, 2003
Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary arteryVincent Sauzeau, Malvyne Rolli-Derkinderen, Stéphanie Lehoux, et al.Cardiovascular Research|August 29, 2006
Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activationYann Gouëffic, Christophe Guilluy, Patrice Guérin, et al.Cardiovascular Research|December 9, 2009
The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migrationGilles Toumaniantz, David Ferland-McCollough, Chrystelle Cario-Toumaniantz, et al.Plos One|September 11, 2015
Hypertension, a Neglected Disease in Rural and Urban Areas in Moramanga, MadagascarRila Ratovoson, Ony Rabarisoa Rasetarinera, Ionimalala Andrianantenaina, et al.British Journal of Pharmacology|September 5, 2002
Role of Rho kinase signalling in healthy and varicose human saphenous veinsChrystelle Cario-Toumaniantz, Sandrine Evellin, Séverine Maury, et al.The Journal of Biological Chemistry|December 5, 2006
Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cellsChristophe Guilluy, Malvyne Rolli-Derkinderen, Pierre-Louis Tharaux, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 10, 2003
Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885Cédric Logé, Valérie Wallez, Elizabeth Scalbert, et al.Pageof 5